- Greer Laboratories' vaccine for bubonic plague has been approved by the US Food and Drug Administration. The vaccine is licensed from Miles-Cutter Laboratories, which produced the bubonic plague vaccine until 1992, whereupon the company stopped production to switch its facility to other purposes. Because the vaccine has already been marketed, Greer only had to show comparability with the Miles vaccine in clinical trials.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze